Search results
Lupin share price jumps 5% after Kotak upgrades stock to an add, raises fair value; here’s what the...
Livemint· 5 hours agoLupin share price: Shares of pharmaceutical player Lupin jumped over 5 per cent in morning trade on...
Emcure Pharmaceuticals IPO opens today: GMP, subscription status, review, other details. Apply or...
Livemint· 1 day agoEmcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price...
Emcure Pharma IPO Day 2: Check Subscription Status, GMP Today - News18
News18· 5 hours agoEmcure Pharma IPO: The initial public offering of Emcure Pharmaceuticals Ltd, which was opened for...
VBL, MRPL among top picks of Anand Rathi for July 04; check key levels here
Business Standard India· 9 hours agoHowever, in the current week, VBL demonstrated resilience by avoiding further drops and instead...
Bansal Wire IPO second day of bidding today: Should you buy or not? Check GMP, key dates,...
Livemint· 7 hours agoBansal Wire IPO subscription status: On the first day of bidding yesterday, Wednesday, July 3, the...
IREDA shares surge 7% to hit one-year high levels; how strong is this upside?
Business Today· 1 day agoShares of Indian Renewable Energy Development Agency Ltd (IREDA) surged 7.20 per cent in Wednesday's...
YES Bank shares give up early gains; here are latest target prices
Business Today· 1 day agoShares of YES Bank Ltd gave up its early gains during the trading session on Wednesday after the initial uptick, post announcing its provisional quarterly updates for the June 2024 quarter.
Emcure Pharma IPO opens today: GMP rises; should you subscribe to the issue? - CNBC TV18
CNBC TV18· 1 day agoThe initial public offering (IPO) of Emcure Pharmaceuticals Ltd. opens for bidding on Wednesday,...
HAL, BEL, other defence stocks gain after govt extends customs duty exemption on imports; should you...
CNBC Awaaz· 6 days agoDefence stocks like Hindustan Aeronautics (HAL), Bharat Dynamics (BDL), Bharat Electronics (BEL) and...
Subscribe- Long Term Emcure Pharmaceuticals Ltd; Anand Rathi
CNBC Awaaz· 2 days agoAnand Rathi, has come out with its report on Emcure Pharmaceuticals Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its research report as on July 02 2024.